Canada-based biotechnology company Ortho Regenerative Technologies has signed an agreement to license technology from Polytechnique Montréal that enables the repair of damaged joints such as the knee or the shoulder.
The agreement was made through Gestion Univalor, the tech transfer office of Polytechnique Montréal, and includes several patent applications. The technology uses a freeze-dried material that turns into microparticles which stimulate healing when they come into contact with a wound.
Ortho has awarded Polytechnique Montréal a three year contract to continue the research and development of the platform. Meanwhile, the company hopes to use the technology as the basis for a range of products focused on joint repairs.
Steve Saviuk, president of Ortho, said: “This platform is built on solid scientific research by leading experts in the field of joint and tissue repair.
“The first focus will be on repair of torn meniscus in the knee. We have seen encouraging data from a recently completed pilot animal model showing the ability to stimulate meniscus healing in joints treated with our technology.
“Additional clinical targets include the repair of articular cartilage and of the rotator cuff.”
